Susquehanna International Group, LLP Virios Therapeutics, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$0.86 - $2.42 $9,460 - $26,620
11,000 New
11,000 $10,000
Q4 2022

Feb 14, 2023
SELL
$0.24 - $0.39 $11,160 - $18,135
-46,500 Reduced 56.02%
36,500 $8,000
Q3 2022

Nov 14, 2022
BUY
$0.37 - $8.77 $30,710 - $727,910
83,000 New
83,000 $32,000

Others Institutions Holding VIRI

# of Institutions
29
Shares Held
1.13M
Call Options Held
0
Put Options Held
0
View Full List

About Virios Therapeutics, Inc.

VIRI Quotes by TradingView
  • Ticker VIRI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,330,400
  • Market Cap $81.4M
  • Description
  • Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...
More about VIRI
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email